Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check4 days agoChange DetectedRevision metadata updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the page. It does not reflect changes to the study details or outcomes.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page shows a new Revision: v3.6.5, replacing the prior v3.6.4, indicating a site version update rather than a change to study information.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small update to the page's version information.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page's revision line now shows version 3.6.3, replacing 3.6.2. This indicates a software release update for the page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now shows revision v3.6.2 in place of the previous v3.6.0, indicating a backend/UI update. This change does not modify the study information presented on the page.SummaryDifference0.0%

- Check83 days agoChange DetectedRecruitment status updated to not enrolling. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, while replacing the older label (Intervention / Treatment) and updating the revision tag to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.